Colombo G, Zucchi A, Allegra F, Colombo P, Zani F, Santi P
Department of Pharmacy, Faculty of Medicine, University of Parma, Italy.
Skin Pharmacol Appl Skin Physiol. 2003 Mar-Apr;16(2):130-6. doi: 10.1159/000069025.
The aim of this work was to study the skin distribution of 5-methoxypsoralen (5-MOP) after application of topical gels, in vitro and in vivo, in both healthy and psoriatic skin sites of 6 psoriatic patients. Drug skin distribution was determined using the thin slicing technique and subsequent HPLC analysis. In the presence of dermatological disease, i.e. psoriasis, the permeability of the tissue changed considerably, leading to an important increase in the cumulative amount of 5-MOP recovered in the skin after topical application. The amount of 5-MOP found in vitro in the human skin was intermediate between those cumulated in healthy and psoriatic skin sites during an in vivo experiment. The gel formulation is an efficacious carrier for the topical photochemotherapy of psoriasis with 5-MOP, since it allows drug penetration in psoriatic skin.
本研究旨在通过体外和体内实验,研究6例银屑病患者健康皮肤部位和银屑病皮肤部位局部应用凝胶后5-甲氧基补骨脂素(5-MOP)的皮肤分布情况。采用薄片切片技术和后续的高效液相色谱分析来测定药物在皮肤中的分布。在存在皮肤病即银屑病的情况下,组织的渗透性发生了显著变化,导致局部应用后皮肤中回收的5-MOP累积量显著增加。在体外人皮肤中发现的5-MOP量介于体内实验中健康皮肤部位和银屑病皮肤部位累积的量之间。该凝胶制剂是用5-MOP进行银屑病局部光化学疗法的有效载体,因为它能使药物渗透到银屑病皮肤中。